<DOC>
	<DOCNO>NCT00568568</DOCNO>
	<brief_summary>The purpose og study investigate effect growth hormon insulin signalling pathways temporal association administration GH develop insulin resistance .</brief_summary>
	<brief_title>Metabolic Studies- Interactions Between GH Insulin GHDA</brief_title>
	<detailed_description>Insulin resistance pathophysiological component type 2 diabetes , obesity elevate blood pressure . Overall syndromes multifactorial ethology partly unclarified pathophysiology . Insulin resistance also occur seldom disease unified pathogenesis . Growth hormone deficiency ( GHD ) adult hypopituitarism example one seldom disease . Prolonged GHD associate abdominal overweight , dyslipidemia increase cardiovascular morbidity . Besides , GHD-patients decrease insulin sensitivity presumably secondary alter body composition . Long term effect GH-substitution improve insulin sensitivity well-known subcutaneous administration GH acute worsen insulin sensitivity muscles- liver-tissue . Recently report insulin resistance patient type 2 diabetes associate induction signal protein call suppressor cytokine signalling ( SOCS ) . ItÂ´s interest GH also induce stimulation SOCS .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Written consent study start Growth Hormone substitution stable dosis least 3 month prior study start Other substitution stable dosis least 3 month prior study start Medical treatment diabetes Hypertension even medical treatment BMI &gt; 30 Excessive alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Growth Hormone</keyword>
	<keyword>GH signal</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Insulin Signaling</keyword>
</DOC>